Grifols S.A. is a leading global biopharmaceutical company specializing in the collection, processing, and transformation of human plasma into life-saving medicines. Founded in 1909 and headquartered ... Grifols S.A. is a leading global biopharmaceutical company specializing in the collection, processing, and transformation of human plasma into life-saving medicines. Founded in 1909 and headquartered in Barcelona, the firm operates across four main business lines: Bioscience, Hospital, Diagnostic, and Raw Materials. The Bioscience division is particularly notable for its focus on developing therapeutic products derived from plasma, which are essential for treating chronic and rare conditions such as immune deficiencies and bleeding disorders. Grifols maintains a significant manufacturing presence with production facilities in Europe, the United States, Mexico, and Australia, and distributes its products to more than 100 countries. By directly operating plasma donation centers worldwide, Grifols has established itself as one of the largest plasma companies, supporting resilient supply chains and innovation in transfusion medicine. The company employs more than 23,000 people and holds a strong reputation within the health technology sector, underpinning its substantial role in the global pharmaceuticals market.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Financial Fundamentals data not yet covered for Grifols

We have not yet reviewed Grifols's disclosures for Financial Fundamentals data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Grifols's data?

Start your 30-day free trial to request a data review for Grifols.

Start Free Trial

Legal Center Contact Us